Sartorius Stedim Biotech (DIM) Stock Chart & Stock Price History €200.40 -1.00 (-0.50%) As of 07/9/2025 Add Compare Share Share Chart Stock AnalysisChartHeadlinesBuy This Stock Sartorius Stedim Biotech Stock Price Performance The Sartorius Stedim Biotech (DIM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 27.64%, with a year-to-date return of 8.77%. In the past month, the stock has increased 3.25%, reflecting recent market activity. As of the latest close, Sartorius Stedim Biotech traded at €201.40 with a market cap of and volume of 55,366 shares. Receive DIM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.29%1 Month Performance+3.25%3 Month Performance+28.79%Year-To-Date Performance+8.77%1 Year Performance+27.64% DIM Stock Chart for Thursday, July, 10, 2025 DIM Chart by TradingView Sartorius Stedim Biotech Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/09/2025€200.20€201.40+0.60%€202.20€195.2555,366 shs$0.0007/08/2025€203.90€200.20-1.81%€203.80€200.0031,885 shs$0.0007/07/2025€203.90€203.90€206.70€201.0039,680 shs$0.0007/04/2025€205.10€204.00-0.54%€207.30€203.1029,677 shs$0.0007/03/2025€203.50€205.10+0.79%€206.30€200.5049,969 shs$0.0007/02/2025€202.80€203.50+0.35%€203.60€199.3072,587 shs$0.0007/01/2025€204.60€202.80-0.88%€207.20€202.4045,322 shs$0.0006/30/2025€204.60€204.60€207.60€202.4040,308 shs$0.0006/27/2025€198.70€203.80+2.57%€208.50€199.5560,045 shs$0.0006/26/2025€199.30€198.70-0.30%€203.60€198.7050,294 shs$0.00 Get the Latest News and Ratings for DIM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter. 06/25/2025€194.85€199.30+2.28%€202.40€198.8568,586 shs$0.0006/24/2025€201.20€194.85-3.16%€198.85€193.0058,108 shs$0.0006/23/2025€201.20€201.20€205.50€201.20190,887 shs$0.0006/20/2025€197.05€202.40+2.72%€204.20€194.5560,154 shs$0.0006/19/2025€197.80€197.05-0.38%€197.65€194.3567,360 shs$0.0006/18/2025€204.40€197.80-3.23%€204.00€197.7070,601 shs$0.0006/17/2025€199.05€204.40+2.69%€205.60€194.1578,801 shs$0.0006/16/2025€199.05€199.05€203.20€198.8046,694 shs$0.0006/13/2025€202.20€203.00+0.40%€204.60€199.0041,710 shs$0.0006/12/2025€198.80€202.20+1.71%€204.00€198.3057,617 shs$0.0006/11/2025€194.10€198.80+2.42%€198.80€194.3547,318 shs$0.0006/10/2025€193.65€194.10+0.23%€196.70€193.2035,271 shs$0.0006/09/2025€193.65€193.65€195.30€189.1037,363 shs$0.00 Related Companies Fielmann Group Stock Price Chart Sartorius Aktiengesellschaft Stock Price Chart Sartorius Aktiengesellschaft Stock Price Chart Carl Zeiss Meditec Stock Price Chart Gerresheimer Stock Price Chart Fresenius SE & Co. KGaA Stock Price Chart Genfit Stock Price Chart Sanofi Stock Price Chart Siemens Healthineers Stock Price Chart Merck KGaA Stock Price Chart Receive DIM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (EPA:DIM) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting—or plan to collect—Social Security, this could be a game-changer. A new initiative tie...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sartorius Stedim Biotech S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sartorius Stedim Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
